PPARA and alcoholic fatty liver disease: KEGG pathway enrichment analysis via Metascape (p < 0.01) revealed that SJGS exerted hypolipidemic effects by modulating PPAR, AMPK, PI3K-Akt, lipid metabolism, and non-alcoholic fatty liver disease pathways.